Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 1000-1007 , August 1995

Modulation of glycogen phosphorylase activity and fructose 2,6-bisphosphate levels by glibenclamide and meglitinide in isolated rat hepatocytes: A comparative study

  • Luisa López-Alarcón

      Affiliations

    • Servicio de Bioquimica Experimental and Servicio de Endocrinologia Experimental, Hospital Puerta de Hierro, Madrid, Spain
    • Departamento de Bioquimica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain
    • ,
  • Maria J. Muñoz-Alonso

      Affiliations

    • Servicio de Bioquimica Experimental and Servicio de Endocrinologia Experimental, Hospital Puerta de Hierro, Madrid, Spain
    • Departamento de Bioquimica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain
    • ,
  • Carmen Guijarro

      Affiliations

    • Servicio de Bioquimica Experimental and Servicio de Endocrinologia Experimental, Hospital Puerta de Hierro, Madrid, Spain
    • Departamento de Bioquimica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain
    • ,
  • Juan E. Feliu

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Juan E. Feliu, MD, PhD, Servicio de Endocrinologia Experimental, Hospital Puerta de Hierro, San Martin de Porres, 4, 28035-Madrid, Spain.
    • Servicio de Bioquimica Experimental and Servicio de Endocrinologia Experimental, Hospital Puerta de Hierro, Madrid, Spain
    • Departamento de Bioquimica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain

Received 13 June 1994 ,Accepted 6 December 1994.

References 

  1. Melander HE, Lebovitz HE, Faber OK. Sulfonylureas: Why; which, how. Diabetes Care. 1990;13(suppl 3):18–25
  2. Matsutani A, Kaku K, Kaneko T. Tolbutamide stimulated fructose 2,6-bisphosphate formation in perfused rat liver. Diabetes. 1984;33:495–498
  3. Hatao K, Kaku K, Matsuda M, et al.  Sulfonylurea stimulates liver fructose 2,6-bisphosphate formation in proportion to its hypoglycemic action. Diabetes Res Clin Pract. 1985;1:49–53
  4. Monge L, Mojena M, Ortega JL, et al.  Chlorpropramide raises fructose 2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Diabetes. 1986;35:89–96
  5. Kaku K, Matsuda M, Matsutani A, et al.  Effect of tolbutamide on fructose 6-phosphate 2-kinase and fructose 2,6-bisphosphatase in rat liver. Biochem Biophys Res Commun. 1986;139:687–692
  6. Cabello MA, Monge L, Ortega JL, et al.  Effect of glipizide on hepatic fructose 2,6-bisphosphate concentration and glucose metabolism. Metabolism. 1987;36:738–742
  7. López-Alarcón L, Berbil-Bautista PR, Guijarro C, et al.  Glipentide and glucose metabolism in isolated rat hepatocytes. Biochem Pharmacol. 1988;37:3177–3182
  8. López-Alarcón L, Melián E, Berbil-Bautista PR, et al.  Modulation of glucose metabolism by sulfonylureas in primary cultures of adult rat hepatocytes. Biochem Int. 1990;21:1125–1134
  9. Pilkis SJ, El-Magrhabi MR, Claus TH. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem. 1988;57:755–784
  10. Mojena M, Marcos ML, Monge L, et al.  Effect of sulfonylureas on hepatic glycogen metabolism: Activation of glycogen phosphorylase. Metabolism. 1989;38:466–470
  11. López-Alarcón L, Melián E, Muñoz-Alonso MJ, et al.  Sulfonylureas activate glycogen phosphorylase and increase cytosolic free Ca2+ levels in isolated rat hepatocytes. Metabolism. 1993;42:624–630
  12. Geisen K, Hübner M, Hitzel V, et al.  Acyl-aminoalkylsubstituierte Benzoe und Phenyl-alkansäure mit blut-glucosesenkender Wirkung. Arzneimittelforschung. 1978;28:1081–1083
  13. Ribes G, Trimble ER, Blayac JP, et al.  Effect of a new hypoglycaemic agent (HB699) on the in vivo secretion of pancreatic hormones in the dog. Diabetologia. 1981;20:501–505
  14. Garrino MG, Schmeer W, Nenquin M, et al.  Mechanism of the stimulation of insulin release in vitro by HB699. In: a benzoic acid derivative similar to the nonsulphonylurea moiety of glybenclamide. ed 8. Diabetologia. 28:1985;p. 697–703
  15. Panten U, Schwanstecher M, Schwanstecher C. Pancreatic and extrapancreatic sulfonylurea receptors. Horm Metab Res. 1992;24:549–554
  16. Ashcroft SJH, Ashcroft FM. The sulfonylurea receptor. Biochim Biophys Acta. 1992;1175:45–59
  17. Felíu JE, Hue L, Hers HG. Hormonal control of pyruvate kinase activity and gluconeogenesis in isolated rat hepatocytes. In: ed 8. Proc Natl Acad Sci USA. 73:1976;p. 2762–2766
  18. Van Schaftingen E, Lederer B, Bartrons R. A kinetic study of pyrophosphate fructose 6-phosphate phosphotransferase from potato tubers. In: Application to a microassay of fructose 2,6-bisphosphate. ed 8. Eur J Biochem. 129:1982;p. 191–195
  19. Hohorst HJ. d-Glucose 6-phosphate and d-fructose 6-phosphate. In: Determination with glucose 6-phosphate dehydrogenase and phosphoglucose isomerase. ed 8.  Bergmeyer HU editors. Methods in Enzymatic Analysis. New York, NY: Academic; 1965;p. 134–138
  20. Lamprecht W, Trautschold I. ATP determination with hexokinase and glucose 6-phosphate dehydrogenase. In: ed 8.  Bergmeyer HU editors. Methods in Enzymatic Analysis. New York, NY: Academic; 1965;p. 543–551
  21. Adam H. Determination of adenosine-5′-diphosphate and adenosine-5′-monophosphate. In: ed 8.  Bergmeyer HU editors. Methods in Enzymatic Analysis. New York, NY: Academic; 1965;p. 573–577
  22. Felíu JE, Mojena M, Silvestre RA, et al.  Stimulatory effect of vasoactive intestinal peptide on glycogenolysis and on gluconeogenesis in isolated rat hepatocytes. In: Antagonism by insulin. ed 8. Endocrinology. 112:1983;p. 2120–2127
  23. Lowry OH, Rosebrough NJ, Farr A, et al.  Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275
  24. Stalmans W, Hers HG. The stimulation of liver phosphorylase b by AMP, fluoride and sulfate. In: A technical note on the specific determination of a and b forms of liver glycogen phosphorylase. ed 8. Eur J Biochem. 54:1975;p. 341–350
  25. Bartrons R, Hue L, Van Schaftingen E. Hormonal control of fructose-2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem J. 1983;214:829–837
  26. Van Schaftingen E, Davies DR, Hers HG. Fructose 2,6bisphosphatase from rat liver. Eur J Biochem. 1982;124:143–149
  27. Mojena M, Boscá L, Hue L. Effect of glutamine on fructose 2,6-bisphosphate and on glucose metabolism in HeLa cells and in chick-embryo fibroblasts. Biochem J. 1985;232:521–527
  28. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–3450
  29. Hue L, Felíu JE, Hers HG. Control of gluconeogenesis and of enzymes of glycogen metabolism in isolated rat hepatocytes. In: A parallel study of the effect of phenylephrine and of glucagon. ed 8. Biochem J. 176:1978;p. 791–797
  30. Boyd AE, Aguilar-Bryan L, Nelson DA. Molecular mechanisms of action of glyburide on the beta cell. Am J Med. 1990;89(suppl 2A):3S–9S
  31. Malaisse WJ, Lebrun P. Mechanisms of sulfonylurea-induced insulin release. Diabetes Care. 1990;13(suppl 3):9–17
  32. Panten U, Burgfeld J, Goerke F, et al.  Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem Pharmacol. 1989;38:1217–1229
  33. Feldman JM, Levobitz HE. Appraisal of the extrapancreatic actions of sulfonylureas. Arch Intern Med. 1969;123:314–322
  34. Beck-Nielsen H, Hother-Nielsen O, Pedersen O. Mechanism of action of sulfonylureas with special reference to the extrapancreatic effect. In: An overview. ed 8. Diabetic Med. 5:1988;p. 613–620
  35. Defronzo RA, Simonson DC. Oral sulfonylurea agents suppress hepatic glucose production in non—insulin-dependent diabetic individuals. Diabetes Care. 1984;7(suppl 1):72–80
  36. Caro JF. Effects of glyburide on carbohydrate metabolism and insulin action in the liver. Am J Med. 1990;89(suppl 2A):17S–25S
  37. Schonborn JW, Poser W, Panten U, et al.  Effect of hypoglycemic sulfonylureas on hepatic fructose metabolism in the rat. Horm Metab Res. 1974;6:284–289
  38. Patel TB. Effects of tolbutamide on gluconeogenesis and glycolysis in perfused rat liver. Am J Physiol. 1986;250:E82–E86
  39. McCormick KM, Williams C, Sicoli R, et al.  Effect of tolazamide on basal ketogenesis, glycogenesis and gluconeogenesis in liver obtained from normal and diabetic rats. Endocrinology. 1986;119:1268–1273
  40. Bernardi H, Lazdunski M. Characterization of the sulfonylurea-sensitive ATP-modulated potassium channel. In: ed 8.  Glossman H,  Striessnig J editor. Methods in Pharmacology. vol 7:New York, NY: Plenum; 1993;p. 61–75
  41. Martz A, Jo I, Jung CY. Sulfonylurea binding to adipocyte membranes and potentiation of insulin-stimulated hexose transport. J Biol Chem. 1989;264:13672–13678
  42. Altan N, Altan VM, Mikolay L, et al.  Insulin-like and insulin-enhancing effects of the sulfonylurea glyburide on rat adipose tissue glycogen synthase. Diabetes. 1985;34:281–286
  43. Cooper DR, Vila MC, Watson JE, et al.  Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes. Diabetes. 1990;39:1399–1407
  44. Norlund L, Sehlin J. The acyl-amino-alkyl benzoic acid residue and the sulfonylurea containing residue of glibenclamide affect different aspects of β-cell function. Acta Physiol Scand. 1984;120:283–286
  45. Norlund L, Sehlin J. Different effects of glibenclamide and the structural analogue HB 699 on the 45Ca2+ uptake by ob/ob-mouse islets. Acta Physiol Scand. 1984;122:187–190
  46. Deleers M, Malaisse WJ. Binding of hypoglycemic sulfonylureas to an artificial bilayer. Diabetologia. 1984;26:55–59
  47. Couturier E, Malaisse WJ. Insulinotropic effects of hypoglycaemic sulphonamides: The ionophoretic hypothesis. Diabetologia. 1980;19:335–340

☆ Supported by a grant (PM90/0088) from Dirección General de Investigación Cientifica y Técnica (DGICYT), Ministerio de Educación y Ciencia, Spain. M.J.M.A. is a predoctoral fellow from DGICYT.

PII: 0026-0495(95)90096-9

Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 1000-1007 , August 1995

Article Tools